NeuroAiD Safe Treatment Registry
NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects
Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD
Study of NeuroAid In Enhancing Recovery After Stroke
CHInese Medicine NeuroAid Efficacy on Stroke Recovery
Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine
Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke
† Study has passed its completion date and status has not been verified in more than two years.